FIELD: chemistry.
SUBSTANCE: thrombocyte aggregation-inhibiting heteromeric peptides based on imidazo[4,5-e]benzo[1,2-c;3,4-c']difuroxane are disclosed: , where R=Phe-Ile-Ala-Asp-Thr; Arg-Tyr-Gly-Asp-Arg; Lys-Ile-Ala-Asp-Asp; His-Ile-Gly-Asp-Asp.
EFFECT: improved properties.
1 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
THROMBOCYTE AGGREGATION-INHIBITING N-CARB(ARGINYL)OXYMETHYLIMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2549355C1 |
THROMBOCYTE AGGREGATION-INHIBITING N-CARB(GLUTAMINYL)OXYMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2012 |
|
RU2502739C9 |
RGD-LIKE PEPTIDES | 2009 |
|
RU2396271C1 |
N-CARBOXYMETHYLIMIDAZO[4,5-e]BENZO[1,2-c;3,4-c']DIFUROXANE | 2014 |
|
RU2544547C1 |
METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
RGD-CONTAINING PEPTIDES | 2001 |
|
RU2214416C2 |
EXENATIDE ANALOGUE | 2020 |
|
RU2823623C1 |
METHOD FOR PRODUCING N-CARBETOXIMETHYLIMIDEAZO[4,5-e]BENZO[1,2-c;3,4-c']DYFUROXANE | 2016 |
|
RU2618230C1 |
METHOD FOR PRODUCTION OF N-CARBETHOXYMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2017 |
|
RU2663846C1 |
Authors
Dates
2015-05-10—Published
2014-04-28—Filed